Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: So then EMTNESTER

Not really...I posted a while ago and many here are starting to agree...that what we need...is JT on the Q for the 15th in January to give a forecasted EPS for 08 and maybe beyond. An earnings guidance would not violate the agreement in Texas....unless the MOU...has in it....specifically...no EPS guidance...which I would doubt it would.

If we can get JT to do that...the sharehodlers and the "street" now has some of it's uncertainty eliminated. The Q/K in April will be so filled with licenses that one will not be able to discern which of the signees paid what. I would also expect JT to give a conservative estimate in the guidance so as not to disappoint those who track that...and by the same means whne we "beat it" we will soar.

Share
New Message
Please login to post a reply